Abbott Laboratories (ABT) EBITDA Margin (QoQ) (2009 - 2026)
Abbott Laboratories (ABT) EBITDA Margin (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.22 Bn | 196.62 Bn | 7.27 Bn |
| 2 | Stryker | 126.75 Bn | 123.28 Bn | 4.50 Bn |
| 3 | Medtronic | 119.49 Bn | 110.27 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.69 Bn | 74.15 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.85 Bn | 47.59 Bn | 1.35 Bn |
| 6 | Dexcom | 34.83 Bn | 32.88 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.81 Bn | 31.70 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.31 Bn | 22.99 Bn | 4.55 Bn |
| 9 | Steris | 23.22 Bn | 22.74 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.26 Bn | 18.85 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 140.00 |
| Mar 31, 2026 | -760.00 |
| Dec 31, 2025 | 155.00 |
| Sep 30, 2025 | -32.00 |
| Jun 30, 2025 | 207.00 |
| Mar 31, 2025 | -107.00 |
| Dec 31, 2024 | -7.00 |
| Sep 30, 2024 | 140.00 |
| Jun 30, 2024 | 217.00 |
| Mar 31, 2024 | -347.00 |
| Dec 31, 2023 | 114.00 |
| Sep 30, 2023 | 78.00 |
| Jun 30, 2023 | -3.00 |
| Mar 31, 2023 | 256.00 |
| Dec 31, 2022 | -408.00 |
| Sep 30, 2022 | -410.00 |
| Jun 30, 2022 | -337.00 |
| Mar 31, 2022 | 374.00 |
| Dec 31, 2021 | -256.00 |
| Sep 30, 2021 | 968.00 |